State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
-3.65%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.2B
AUM Growth
-$3.58B
(-6.9%)
Cap. Flow
-$581M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
2,541
New
398
Increased
831
Reduced
708
Closed
271
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$809M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$244M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$185M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$104M |
| 5 |
S&P Global
SPGI
|
+$75.1M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$199M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$154M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$118M |
| 4 |
Elevance Health
ELV
|
+$116M |
| 5 |
Microsoft
MSFT
|
+$88.6M |
Sector Composition
| 1 | Technology | 23.12% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
argenx
ARGX
$46.7B
| $1.19M | ﹤0.01% |
3,757
-3,008
| -44% | -$949K |
|
1602
Atea Pharmaceuticals
AVIR
$250M
| $1.18M | ﹤0.01% |
163,800
+80,200
| +96% | +$579K |
|
|
LIVBU
1603
DELISTED
LIV Capital Acquisition Corp. II Unit
LIVBU
| $1.18M | ﹤0.01% |
+114,669
| New | +$1.18M |
|
|
RETA
1604
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.17M | ﹤0.01% |
35,800
| – | – |
|
|
IGMS
1605
DELISTED
IGM Biosciences
IGMS
| $1.17M | ﹤0.01% |
43,800
+33,700
| +334% | +$901K |
|
|
IMGN
1606
DELISTED
Immunogen Inc
IMGN
| $1.17M | ﹤0.01% |
245,100
-40,800
| -14% | -$194K |
|
1607
MacroGenics
MGNX
$104M
| $1.16M | ﹤0.01% |
131,500
+57,700
| +78% | +$508K |
|
|
TCN
1608
DELISTED
Tricon Residential Inc.
TCN
| $1.16M | ﹤0.01% |
72,766
-29,412
| -29% | -$468K |
|
|
WW
1609
DELISTED
WW International
WW
| $1.15M | ﹤0.01% |
112,800
+49,700
| +79% | +$508K |
|
1610
Aurinia Pharmaceuticals
AUPH
$1.68B
| $1.13M | ﹤0.01% |
+91,300
| New | +$1.13M |
|
1611
Rhythm Pharmaceuticals
RYTM
$6.5B
| $1.13M | ﹤0.01% |
97,900
+49,500
| +102% | +$570K |
|
|
BMAC
1612
DELISTED
Black Mountain Acquisition Corp.
BMAC
| $1.13M | ﹤0.01% |
113,445
+11,925
| +12% | +$118K |
|
1613
QCR Holdings
QCRH
$1.32B
| $1.13M | ﹤0.01% |
19,900
| – | – |
|
|
BLDP
1614
Ballard Power Systems
BLDP
$616M
| $1.12M | ﹤0.01% |
96,390
-24,764
| -20% | -$289K |
|
1615
Generation Bio
GBIO
$40.3M
| $1.12M | ﹤0.01% |
15,280
+9,850
| +181% | +$723K |
|
1616
MannKind Corp
MNKD
$1.66B
| $1.12M | ﹤0.01% |
304,900
-70,800
| -19% | -$261K |
|
1617
Nuvation Bio
NUVB
$1.15B
| $1.12M | ﹤0.01% |
212,800
+166,600
| +361% | +$876K |
|
1618
Technology Select Sector SPDR Fund
XLK
$86.6B
| $1.11M | ﹤0.01% |
7,009
+3,295
| +89% | +$524K |
|
1619
Ralph Lauren
RL
$18.9B
| $1.11M | ﹤0.01% |
9,770
+929
| +11% | +$105K |
|
1620
Catalyst Pharmaceutical
CPRX
$2.42B
| $1.1M | ﹤0.01% |
132,400
-39,300
| -23% | -$326K |
|
1621
Y-mAbs Therapeutics
YMAB
$390M
| $1.09M | ﹤0.01% |
92,100
+51,100
| +125% | +$607K |
|
|
IVCPU
1622
DELISTED
Swiftmerge Acquisition Corp. Unit
IVCPU
| $1.09M | ﹤0.01% |
110,000
+10,000
| +10% | +$99.3K |
|
1623
Recursion Pharmaceuticals
RXRX
$2.12B
| $1.09M | ﹤0.01% |
152,300
| – | – |
|
|
ARTA
1624
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
| $1.09M | ﹤0.01% |
110,000
| – | – |
|
1625
C4 Therapeutics
CCCC
$194M
| $1.08M | ﹤0.01% |
44,500
| – | – |
|